<DOC>
	<DOCNO>NCT00857454</DOCNO>
	<brief_summary>Testosterone replacement treatment effective way treat hypogonadism men . Acrux propriety testosterone replacement product , Testosterone MD-Lotion study ass occurrence skin safety event two month continuous use Testosterone MD-LotionÂ® ( cutaneous solution ) completion MTE08 ( NCT00702650 ) trial .</brief_summary>
	<brief_title>A Trial Evaluate Ongoing Skin Safety Testosterone MD-Lotion Formulations</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Hypogonadal males qualify general medical health Completed MTE08 trial include Day 120/121 compliant manner Were able communicate trial staff , understand Trial Information Sheet sign Written Informed Consent Forms ; willing follow Protocol requirement comply Protocol restriction procedures Any clinically significant chronic illness find and/or laboratory test would interfere trial objective safety subject Any man testosterone therapy contraindicate , include : Known suspected carcinoma ( history carcinoma ) prostate clinically significant symptom benign prostatic hyperplasia and/or clinically significant symptom low urinary obstruction International Prostate Symptoms Score ( IPSS ) score great equal 19 Known suspect carcinoma ( history carcinoma ) breast Severe liver disease ( i.e . cirrhosis , hepatitis liver tumours liver function test &gt; 2 time upper limit normal range value Active deep vein thrombosis , thromboembolic disorder document history condition Current significant cerebrovascular coronary artery disease Untreated sleep apnoea Haematocrit &gt; 54 % Untreated moderate severe depression Men clinically significant prostate exam clinically significant elevate serum Prostate Specific Antigen ( PSA ) level ( &gt; 4 ng/mL ) age adjust reference range PSA value Men take concomitant medication ( prescribe , overthecounter complementary ) would affect Sex Hormone Binding Globulin ( SHBG ) testosterone concentration ( exclude Testosterone MDLotion ( cutaneous solution ) ) metabolism warfarin , insulin , opiates , gonadotropinreleasing hormone analogue ( GnRH ) , 5 alpha reductase inhibitor , propanolol , oxyphenbutazone , corticosteroid ( except physiological replacement dos ) , estradiol Men uncontrolled diabetes ( Hemoglobin A1c [ HbA1c ] great equal 10 % ) Subjects intend surgical procedure course trial Subjects partner child bear potential willing use adequate contraception duration trial Subjects whose partner pregnant</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>